In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Comparing the Big 3, Semaglutide, Tirzepatide and Retatrutide : r Mounjaro CagriSema vs Tirzepatide: Amylin GLP 1 vs GIP GLP 1 for Maximum Weight Loss Which Is Better? PPW Peptide Protocol Wiki Cagrilintide: What It Is and How It's Being Studied for Weight Loss